Beryl Capital Management LLC 13D and 13G filings for Inozyme Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-14 12:38 pm Sale | 2025-06-30 | 13G | INOZYME PHARMA INC INZY | Beryl Capital Management LLC | 0 0.000% | -6,321,584 (Position Closed) | Filing |
| 2025-05-23 4:22 pm Purchase | 2025-05-16 | 13G | INOZYME PHARMA INC INZY | Beryl Capital Management LLC | 6,321,584 9.800% | 6,321,584 (New Position) | Filing |